Identification of human T-cell epitopes on Mycobacterium tuberculosis small molecular weight proteins and development of DNA vaccines based on the epitopes
结核分枝杆菌小分子量蛋白上人T细胞表位的鉴定以及基于该表位的DNA疫苗的开发
基本信息
- 批准号:16390130
- 负责人:
- 金额:$ 8.96万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (B)
- 财政年份:2004
- 资助国家:日本
- 起止时间:2004 至 2006
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
CD8^+ cytotoxic T lymphocytes (CTL) play a pivotal role in protection against Mycobacterium tuberculosis infection. We identified a novel CTL epitope on a protective antigen of M. tuberculosis, MPT51, in HLA-A^*0201-transgenic HHD mice. HHD mice were immunized with plasmid DNA encoding MPT51 using gene gun and interferon (IFN)-y production from the immune splenocytes was analyzed. In response to synthetic overlapping peptide library covering the mature MPT51 sequence, only one peptide, p51-70, stimulated the splenocytes to produce IFN-y. Three-color flow cytometric analysis of cell-surface CD4 and CD8 staining revealed that p51-70 peptide contains an immunodominant CD8^+ T-cell epitope. Further analysis using computer-assisted algorithms permitted identification of a bona fide T-cell epitope, p53-62. MHC class I stabilization assay using T2 cells confirmed that the epitope is presented by HLA-A^*0201. MPT51 p53-62/HLA-A^*0201 tetramer was observed to bind to the specific CD8^+ T cells of immune HHD splenocytes. In addition, MPT51 p53-62-specific memory CD8^+ T cells were found in tuberculin skin test-positive HLA-A^*0201^+ healthy individuals. This HLA-A^*0201-restricted CD8^+ T-cell epitope would be feasible for analysis of the role of MPT51-specific T cells in protective immunity and for future vaccine design against M. tuberculosis infection.
CD 8 ^+细胞毒性T淋巴细胞(CTL)在抗结核分枝杆菌感染中起关键作用。我们在M的保护性抗原上鉴定了一个新的CTL表位。结核病,MPT 51,在HLA-A^*0201转基因HHD小鼠中。用基因枪将编码MPT 51的质粒DNA免疫HHD小鼠,并分析免疫脾细胞产生干扰素(IFN)-γ的情况。在对覆盖成熟MPT 51序列的合成重叠肽库的应答中,只有一个肽p51-70刺激脾细胞产生IFN-γ。细胞表面CD 4和CD 8染色的三色流式细胞术分析显示,p51-70肽含有免疫显性的CD 8 ^+ T细胞表位。使用计算机辅助算法的进一步分析允许鉴定真正的T细胞表位,p53-62。使用T2细胞的MHC I类稳定化测定证实表位由HLA-A *0201呈递。观察到MPT 51 p53-62/HLA-A^*0201四聚体与免疫HHD脾细胞的特异性CD 8 ^+ T细胞结合。此外,在结核菌素皮肤试验阳性HLA-A^*0201^+健康个体中发现了MPT 51 p53-62特异性记忆CD 8 ^+ T细胞。这种HLA-A^*0201限制性CD 8 ^+ T细胞表位对于分析MPT 51特异性T细胞在保护性免疫中的作用以及未来针对M.肺结核感染。
项目成果
期刊论文数量(44)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Expression mapping by retroviral vector for CD8+ T cell epitopes : definition of a Mycobacterium tuberculosis peptide presented by H2-D^d.
CD8 T 细胞表位逆转录病毒载体的表达作图:H2-D^d 呈现的结核分枝杆菌肽的定义。
- DOI:
- 发表时间:2005
- 期刊:
- 影响因子:0
- 作者:Aoshi;T.;Suzuki;M.;Uchijima;M.;Nagata;T.;Koide;Y.
- 通讯作者:Y.
Identification of MHC-restricted T-cell epitopes on a novel protective antigen, MPT51, of Mycobacterium tuberculosis.
结核分枝杆菌新型保护性抗原 MPT51 上 MHC 限制性 T 细胞表位的鉴定。
- DOI:
- 发表时间:2004
- 期刊:
- 影响因子:0
- 作者:Koide;Y.;Suzuki;M.;Aoshi;T.;Nagata;T.
- 通讯作者:T.
Identification of H2-D^d- and H2-A^b-restricted T-cell epitopes on a novel protective antigen, MPT51, of Mycobacterium tuberculosis.
结核分枝杆菌新型保护性抗原 MPT51 上 H2-D^d- 和 H2-A^b- 限制性 T 细胞表位的鉴定。
- DOI:
- 发表时间:2004
- 期刊:
- 影响因子:0
- 作者:Suzuki;M.;Aoshi;T.;Nagata;T.;Koide;Y.
- 通讯作者:Y.
Interferon-γ overcomes low responsiveness of myeloid dendritic cells to CpG-DNA.
干扰素-γ 克服了骨髓树突状细胞对 CpG-DNA 的低反应性。
- DOI:
- 发表时间:2005
- 期刊:
- 影响因子:0
- 作者:Uchijima M;Nagata T;Aoshi T;Koide Y
- 通讯作者:Koide Y
Immunization with dendritic cells pulsesd with α-galactocylceramide and a dominant CTL epitope elicits effective protective immunity against intracellular bacteria infection.
用 α-半乳酰神经酰胺和优势细菌 CTL 表位脉冲的树突状细胞进行免疫,可引发针对细胞内感染的有效保护性免疫。
- DOI:
- 发表时间:2006
- 期刊:
- 影响因子:0
- 作者:Enomoto;N.;Nagata;T.;Suda;T.;Uchijima;M.;Chida;K.;Nakamura;H.;Koide;Y.
- 通讯作者:Y.
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
NAGATA Toshi其他文献
Metabolism of ginsenoside Rg1 by intestinal bacteria Ⅱ. Immunological activity of ginsenoside Rg1 and Rh1.
人参皂苷Rg1被肠道细菌代谢Ⅸ。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
Wang Yi;Wang Ben-Xiang;Liu Tie-Han;MINAMI Mutsuhiko;NAGATA Toshi;IKEJIMA Takashi - 通讯作者:
IKEJIMA Takashi
MDP1タンパクのマウスT細胞エピトープの解析/ Characterization of murine T-cell epitopes in Mycobacterial DNA- binding protein 1
分枝杆菌 DNA 结合蛋白 1 中鼠 T 细胞表位的表征
- DOI:
- 发表时间:
2008 - 期刊:
- 影响因子:0
- 作者:
Suzuki Daisuke;NAGATA Toshi;MATSUMOTO Sohkichi;KOIDE Yukiko - 通讯作者:
KOIDE Yukiko
NAGATA Toshi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('NAGATA Toshi', 18)}}的其他基金
Evaluation of the mechanisms underlying carbon cycles mediated by microbial food web networks in meso- and bathypelagic layers of the oceans
评估海洋中层和深海层微生物食物网网络介导的碳循环机制
- 批准号:
24241003 - 财政年份:2012
- 资助金额:
$ 8.96万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Dynamic Control of Molecular Functions via Time-Dependent External Stimuli
通过时间相关的外部刺激动态控制分子功能
- 批准号:
22550133 - 财政年份:2010
- 资助金额:
$ 8.96万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Evaluation of mechanisms underlying the formation of viral hot spot observed in the mid latitude region of the North Pacific
北太平洋中纬度地区病毒热点形成机制的评估
- 批准号:
22651004 - 财政年份:2010
- 资助金额:
$ 8.96万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Resource Recycling of Carbon Dioxide with Catalysis by Heteromultinuclear Metal Complexes
杂多核金属配合物催化二氧化碳资源化
- 批准号:
21200057 - 财政年份:2009
- 资助金额:
$ 8.96万 - 项目类别:
Grant-in-Aid for Scientific Research on Innovative Areas (Research a proposed research project)
Analyses of the dynamic structure of organic matter-bacteria interactions that mediate carbon cycling in meso- and bathypelagic oceans
介导中层和深海海洋碳循环的有机物-细菌相互作用的动态结构分析
- 批准号:
20310010 - 财政年份:2008
- 资助金额:
$ 8.96万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Identification of low-molecular-mass secretory proteins of Mycobacterium tuberculosis and the application to development of anti-tuberculosis vaccines
结核分枝杆菌低分子量分泌蛋白的鉴定及其在抗结核疫苗研制中的应用
- 批准号:
20590438 - 财政年份:2008
- 资助金额:
$ 8.96万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Construction of molecular systems for photosynthetic chemical conversion by artificial quinone pools
人工醌库光合化学转化分子系统的构建
- 批准号:
19550173 - 财政年份:2007
- 资助金额:
$ 8.96万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Microbial and geochemical mechanisms controlling dissolution processes of particulate organic matter in the oceans
控制海洋中颗粒有机物溶解过程的微生物和地球化学机制
- 批准号:
17201004 - 财政年份:2005
- 资助金额:
$ 8.96万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Study on anti-tuburculosis DNA vaccines using attenuated Listeria strain as the carrier
以李斯特菌减毒株为载体的抗结核DNA疫苗的研究
- 批准号:
14570234 - 财政年份:2002
- 资助金额:
$ 8.96万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Biocomplexity of the interactions of complex organic colloids and microbial communities in aquatic environments
水生环境中复杂有机胶体与微生物群落相互作用的生物复杂性
- 批准号:
13308029 - 财政年份:2001
- 资助金额:
$ 8.96万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
相似国自然基金
鲜驴乳中游离脂肪酸对Mycobacterium tuberculosis H37Rv活性的影响及机制研究
- 批准号:31760442
- 批准年份:2017
- 资助金额:38.0 万元
- 项目类别:地区科学基金项目
靶向结核杆菌细胞壁ManLAM的多肽型显像剂,用于鉴别诊断结核病灶与肿瘤病灶的实验研究
- 批准号:30970859
- 批准年份:2009
- 资助金额:32.0 万元
- 项目类别:面上项目
PKB/AKT1介导的结核杆菌感染及防治的分子机制研究
- 批准号:30871117
- 批准年份:2008
- 资助金额:31.0 万元
- 项目类别:面上项目
应用ELISPOT和四聚体技术研究结核与艾滋病相关结核诊断试剂
- 批准号:30430660
- 批准年份:2004
- 资助金额:105.0 万元
- 项目类别:重点项目
相似海外基金
Fragment to small molecule hit discovery targeting Mycobacterium tuberculosis FtsZ
针对结核分枝杆菌 FtsZ 的小分子片段发现
- 批准号:
MR/Z503757/1 - 财政年份:2024
- 资助金额:
$ 8.96万 - 项目类别:
Research Grant
Environmental Reservoirs and Antimicrobial Resistance in Non-tuberculosis Mycobacteria: A Genomic Investigation
非结核分枝杆菌的环境储库和抗菌素耐药性:基因组研究
- 批准号:
502471 - 财政年份:2024
- 资助金额:
$ 8.96万 - 项目类别:
The use of microRNA expression profiling in the detection and prediction of Bovine Tuberculosis
microRNA表达谱在牛结核病检测和预测中的应用
- 批准号:
10096799 - 财政年份:2024
- 资助金额:
$ 8.96万 - 项目类别:
Collaborative R&D
A benefit-risk trial of 1-month rifapentine and isoniazid to prevent tuberculosis and reduce morbidity in people with non-communicable multimorbidity
一项为期 1 个月的利福喷汀和异烟肼预防结核病并降低非传染性多病患者发病率的效益风险试验
- 批准号:
MR/Y004914/1 - 财政年份:2024
- 资助金额:
$ 8.96万 - 项目类别:
Research Grant
Mathematically modelling tuberculosis: using lung scans to map infection, and a hybrid individual-based model to simulate infection and treatment
对结核病进行数学建模:使用肺部扫描来绘制感染图,并使用基于个体的混合模型来模拟感染和治疗
- 批准号:
MR/Y010124/1 - 财政年份:2024
- 资助金额:
$ 8.96万 - 项目类别:
Fellowship
Improving understanding of lung immunity in tuberculosis to establish a diverse, innovative TB vaccine pipeline targeting mucosal immunity
提高对结核病肺免疫的了解,建立针对粘膜免疫的多样化、创新型结核疫苗管道
- 批准号:
10068466 - 财政年份:2023
- 资助金额:
$ 8.96万 - 项目类别:
EU-Funded
Investigating the mechanisms of disease progression in HIV/TB co-infection to design interventions for better clinical outcomes
研究 HIV/TB 合并感染的疾病进展机制,以设计干预措施以获得更好的临床结果
- 批准号:
493476 - 财政年份:2023
- 资助金额:
$ 8.96万 - 项目类别:
Operating Grants
Role of phenotypic heterogeneity in mycobacterial persistence to antibiotics: Prospects for more effective treatment regimens
表型异质性在分枝杆菌对抗生素持久性中的作用:更有效治疗方案的前景
- 批准号:
494853 - 财政年份:2023
- 资助金额:
$ 8.96万 - 项目类别:
Operating Grants
Identifying correlates of risk for future tuberculosis disease progression in children (INTREPID)
确定儿童未来结核病进展风险的相关性 (INTREPID)
- 批准号:
10637036 - 财政年份:2023
- 资助金额:
$ 8.96万 - 项目类别:
Mechanistic Studies of Gyrase/Topoisomerase IV-Targeted Antibacterials
旋转酶/拓扑异构酶 IV 靶向抗菌药物的机理研究
- 批准号:
10667862 - 财政年份:2023
- 资助金额:
$ 8.96万 - 项目类别:














{{item.name}}会员




